Diabetes: a 21st century challenge (Q38195468)

30 August 2017

1 reference

title

Diabetes: a 21st century challenge (English)

1 reference

30 August 2017

Paul Z Zimmet

1

0 references

author name string

Dianna J Magliano

series ordinal

2

1 reference

PubMed ID

24622669

30 August 2017

William H Herman

series ordinal

3

1 reference

PubMed ID

24622669

30 August 2017

Jonathan E Shaw

series ordinal

4

1 reference

30 August 2017

3 December 2013

1 reference

The Lancet: Diabetes & Endocrinology

30 August 2017

1 reference

30 August 2017

2

1 reference

30 August 2017

56-64

1 reference

30 August 2017

1

1 reference

The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Diabetes mellitus in American (Pima) Indians

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The high prevalence of diabetes mellitus on a Central Pacific Island

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Human evolution. Diabetes running wild

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The epidemiology and natural history of NIDDM--lessons from the South Pacific

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The Tokelau Island migrant study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The prevalence of diabetes in the kingdom of Tonga

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Non-communicable diseases: 2015 to 2025.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Management of diabetes in resource-poor settings.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Explaining the increase of diabetes prevalence and plasma glucose in Mauritius

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Time use and physical activity: a shift away from movement across the globe

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Double diabetes: a mixture of type 1 and type 2 diabetes in youth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Type 2 diabetes in young Indigenous Australians in rural and remote areas: diagnosis, screening, management and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Type 2 diabetes in indigenous Australian children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The incidence, clinical features, and treatment of type 2 diabetes in children <15 yr in a population-based cohort from Auckland, New Zealand, 1995–2007.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Incidence of diabetes in youth in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The levelling off of the obesity epidemic since the year 1999--a review of evidence and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Diabetes epidemiology as a tool to trigger diabetes research and care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Genomewide association studies and assessment of the risk of disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Effect of in utero and early-life conditions on adult health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Cohort Profile: The Dutch Hunger Winter Families Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Glucose tolerance in adults after prenatal exposure to famine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Birth weight and risk of type 2 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Epigenetic mechanisms that underpin metabolic and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Epigenetic changes in diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Persistent epigenetic differences associated with prenatal exposure to famine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Diabetes and associated disorders in Cambodia: two epidemiological surveys

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Gestational diabetes: the need for a common ground

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Global healthcare expenditure on diabetes for 2010 and 2030.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Economic costs of diabetes in the U.S. in 2012

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Economic costs of diabetes in the US in 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Economic costs of diabetes in the U.S. In 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The economic costs of diabetes: is it time for a new treatment paradigm?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Diabetes prevention and treatment strategies: are we doing enough?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Early nutrition and adult outcomes: pieces of the puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

The inter- and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970112-8

7 January 2021

10.1016/S2213-8587(13)70112-8

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24622669